SCHEMBL3932997

SCHEMBL3932997

CC(=O)Nc1ccc(-c2nc3ccc(C)cc3s2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.78
NPC1 O15118 8/20 0.78
RAB9A P51151 8/20 0.78
KDM4E B2RXH2 7/20 0.78
ALDH1A1 P00352 6/20 0.78
SMN1; SMN2 Q16637 5/20 0.78
MEN1 O00255 4/20 0.78
KMT2A Q03164 4/20 0.78
HPGD P15428 3/20 0.78
NPSR1 Q6W5P4 2/20 0.78
RXFP1 Q9HBX9 1/20 0.78
SULT1A1 P50225 1/20 0.77
TP53 P04637 3/20 0.74
LMNA P02545 2/20 0.70
CASP3 P42574 1/20 0.70
SENP8 Q96LD8 1/20 0.70
SENP7 Q9BQF6 1/20 0.70
SENP6 Q9GZR1 1/20 0.70
APP P05067 2/20 0.69
SNCA P37840 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12963239 0.93 MAPT (0.74) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL591019 0.88 SMN1; SMN2 (0.74) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL10599193 0.86 NPC1 (0.80) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL12207363 0.86 SULT1A1 (0.75) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL27451359 0.85 NPC1 (0.68) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL28669948 0.85 SMN1; SMN2 (0.74) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL29466151 0.85 SMN1; SMN2 (0.74) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL24185813 0.84 SMN1; SMN2 (0.87) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL1984153 0.84 MMP2 (0.74) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL27451198 0.84 SMN1; SMN2 (0.69) MAPTNPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1344055-A4 MATERIALS FOR ENHANCING STAINING OF BIOPOLYMERS IN MATRICES INVITROGEN CORP (US) 2009-03-25 EP disclosed
WO-2008017840-A1 CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES MERLION PHARMACEUTICALS SA (CH) 2008-02-14 WO disclosed
US-7144738-B2 Materials for enhancing staining of biopolymers in matrices WHITNEY SCOTT 2006-12-05 US disclosed
US-20050170517-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION (US) 2005-08-04 US disclosed
US-6878551-B2 For proteins/polypeptides within polyacrylamide matrix; mass spectrometry INVITROGEN CORPORATION (US) 2005-04-12 US disclosed
US-20040038418-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION 2004-02-26 US disclosed
US-6635489-B2 Sensitizing the matrix with heteroaromatic compounds, contacting with reduceable metal salts to stain and detecting INVITROGEN CORPORATION 2003-10-21 US disclosed
EP-1344055-A1 MATERIALS FOR ENHANCING STAINING OF BIOPOLYMERS IN MATRICES INVITROGEN CORPORATION (US) 2003-09-17 EP disclosed
US-20020137222-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION 2002-09-26 US disclosed
WO-2002042764-A1 MATERIALS FOR ENHANCING STAINING OF BIOPOLYMERS IN MATRICES INVITROGEN CORPORATION (US) 2002-05-30 WO disclosed
US-4324682-A PRESSURE RUPTURABLE; FOR MARKING AND IDENTIFICATION AMERICAN CYANAMID COMPANY (US) 1982-04-13 US disclosed
US-3960755-A Detecting compositions and method of using same AMERICAN CYANAMID COMPANY (US) 1976-06-01 US disclosed